Oct 25, 2026 04:35AM
Oct 25, 2026 04:35AM
Sep 1, 2026 09:07AM
Aug 5, 2026 04:01PM
May 18, 2026 08:34AM
Dec 21, 2025 04:00AM
Aug 6, 2025 04:01PM Xencor Reports Second Quarter 2025 Financial Results
May 7, 2025 04:01PM
May 9, 2024 04:09PM
May 5, 2022 04:01PM
Feb 24, 2022 06:00AM
Feb 23, 2022 04:01PM
Aug 4, 2021 04:01PM
May 26, 2021 07:46PM Sotrovimab (VIR-7831), an Investigational Antibody Utilizing Xencor's Xtend™ Technology, Receives U.S. FDA Emergency Use Authorization for the Treatment of COVID-19
May 5, 2021 04:01PM
Feb 25, 2021 05:01AM
Feb 23, 2021 04:01PM
Dec 29, 2020 07:42AM
Nov 11, 2020 04:04PM
Nov 11, 2020 04:02PM
Nov 5, 2020 04:01PM Xencor Reports Third Quarter 2020 Financial Results
Aug 4, 2020 04:01PM
Jul 31, 2020 10:49PM
May 7, 2020 04:01PM
Feb 24, 2020 04:01PM
Feb 5, 2020 08:08AM
Dec 18, 2019 08:01AM
Nov 5, 2019 04:01PM Xencor Reports Third Quarter 2019 Financial Results
May 9, 2019 04:00PM
Apr 30, 2019 08:12AM
Apr 30, 2019 08:01AM
Feb 25, 2019 04:24PM
Feb 20, 2019 07:09AM
Feb 20, 2019 06:55AM
Nov 8, 2018 09:05AM Xencor (XNCR) Names Ellen G. Feigal M.D. to Board
Nov 8, 2018 09:01AM
Nov 5, 2018 04:01PM
May 7, 2018 04:01PM
Mar 21, 2018 09:13AM
Feb 27, 2018 04:01PM
Jan 5, 2018 08:10AM
Jan 5, 2018 08:00AM Xencor Announces 2018 Priorities and Expected Milestones
Nov 7, 2017 04:01PM
Aug 7, 2017 04:01PM
May 11, 2017 08:09AM
May 11, 2017 08:00AM
Apr 17, 2017 08:03AM
Apr 17, 2017 08:00AM
Feb 28, 2017 04:06PM Xencor Reports Fourth Quarter and Full Year 2016 Financial Results

335,228 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All